Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Type I Interferons in Autoimmunity
Ruth Fernandez‐Ruiz, Timothy B. Niewold
Journal of Investigative Dermatology (2022) Vol. 142, Iss. 3, pp. 793-803
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

The crucial regulatory role of type I interferon in inflammatory diseases
Ling Ji, Tianle Li, Huimin Chen, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 28
The pseudorabies virus UL13 protein kinase triggers phosphorylation of the RNA demethylase FTO, which is associated with FTO-dependent suppression of interferon-stimulated gene expression
Ruth Verhamme, Robert J. J. Jansens, Jianheng Liu, et al.
Journal of Virology (2025)
Open Access | Times Cited: 1
Type I Interferons in Autoimmunity: Implications in Clinical Phenotypes and Treatment Response
Ana Carolina Londe, Ruth Fernandez‐Ruiz, Paulo Rogério Júlio, et al.
The Journal of Rheumatology (2023) Vol. 50, Iss. 9, pp. 1103-1113
Open Access | Times Cited: 19
Inflammatory cytokines and their potential role in Sjogren’s syndrome risk: insights from a mendelian randomization study
Wenbin Shi, Yuli Xu, Anan Zhang, et al.
Advances in Rheumatology (2024) Vol. 64, Iss. 1
Open Access | Times Cited: 7
PANoptosis Features, a Humanized NSG Murine Model of Sjogren's Syndrome
Yiying Yang, Huali Zhang, Xiaoyu Xiao, et al.
DNA and Cell Biology (2024) Vol. 43, Iss. 5, pp. 207-218
Closed Access | Times Cited: 6
Type I Interferons and Systemic Lupus Erythematosus
向阳 张
Medical Diagnosis (2025) Vol. 15, Iss. 02, pp. 140-147
Closed Access
Intermittent hypoxia exacerbates anxiety in high-fat diet-induced diabetic mice by inhibiting TREM2-regulated IFNAR1 signaling
Wenyu Ni, Yun Niu, Sitong Cao, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 4
Profiling Type I and II Interferon Responses Reveals Distinct Subgroups of Pediatric Patients with Autoinflammatory Disorders
Anaïs Nombel, Magali Perret, Sophie Trouillet‐Assant, et al.
Journal of Allergy and Clinical Immunology Global (2025) Vol. 4, Iss. 2, pp. 100450-100450
Open Access
Immunohistochemical analysis reveals higher Myxovirus resistance protein 1 expression and increased macrophage count in placentas from patients with systemic rheumatic diseases
Juan J. Fierro, Mirthe H. Schoots, S.C. Liefers, et al.
Rheumatology International (2025) Vol. 45, Iss. 4
Open Access
Rapid Detection of Anti‐IFN‐α2 Autoantibodies Using a New Automated VIDAS Assay Prototype
Sylvie Pons, Laurence Generenaz, Adrian Gervais, et al.
European Journal of Immunology (2025) Vol. 55, Iss. 4
Open Access
Five genes as diagnostic biomarkers of dermatomyositis and their correlation with immune cell infiltration
Xiaohu Zhao, Shangkun Si
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Mesenchymal stem cell transplantation alleviates Sjögren's syndrome symptoms by modulating Tim-3 expression
Tian Sun, Shanshan Liu, Guangxia Yang, et al.
International Immunopharmacology (2022) Vol. 111, pp. 109152-109152
Closed Access | Times Cited: 13
Construction of a Multi-Indicator Model for Abscess Prediction in Granulomatous Lobular Mastitis Using Inflammatory Indicators
Nannan Du, Jiamei Feng, Shijun Shao, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 553-564
Open Access | Times Cited: 2
Bi-directional regulation of type I interferon signaling by heme oxygenase-1
Miaomiao Wu, Yihui Fan, Lijuan Li, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109185-109185
Open Access | Times Cited: 2
Interferon-induced protein 44 ( IFI44 ) and interferon regulatory factor 4 ( IRF4 ) gene expression in rheumatoid arthritis
Shaimaa Elsayed Ramadan Genena, Maha A. f. Hamouda, N Salama, et al.
Journal of Immunoassay and Immunochemistry (2024) Vol. 45, Iss. 5, pp. 432-451
Closed Access | Times Cited: 2
Single cell analysis of docosahexaenoic acid suppression of sequential LPS-induced proinflammatory and interferon-regulated gene expression in the macrophage
Kathryn A. Wierenga, Frank M. Riemers, Bart Westendorp, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
LTN1 promotes RLR degradation to inhibit immune response to RNA virus through the ESCRT pathway
Fei Qin, Baoshan Cai, Peng Wang, et al.
Autophagy (2023) Vol. 20, Iss. 6, pp. 1270-1285
Closed Access | Times Cited: 5
Nucleic acid-sensing toll-like receptors: Important players in Sjögren’s syndrome
Lena Alexopoulou
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Targeting cyclin-dependent kinases in rheumatoid arthritis and psoriasis – a review of current evidence
Marzena Staniszewska, Kajetan Kiełbowski, Klaudia Rusińska, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 11, pp. 1097-1113
Closed Access | Times Cited: 4
Multi-omics analysis uncovered systemic lupus erythematosus and COVID-19 crosstalk
Zekai Nian, Yicheng Mao, Zexia Xu, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 1
Toll-like Receptor Homologue CD180 Ligation of B Cells Upregulates Type I IFN Signature in Diffuse Cutaneous Systemic Sclerosis
Szabina Erdő-Bonyár, Judit Rapp, Rovéna Subicz, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7933-7933
Open Access | Times Cited: 1
Type I Interferons in Systemic Autoimmune Rheumatic Diseases: Pathogenesis, Clinical Features and Treatment Options
Konstantinos Drougkas, Charalampos Skarlis, Clio P. Mavragani
Mediterranean Journal of Rheumatology (2024) Vol. 35, Iss. Suppl 2, pp. 365-365
Open Access | Times Cited: 1
A comprehensive review of Sjögren's syndrome: classification criteria, risk factors, and signaling pathways
Ting Zhao, Runrun Zhang, Zhaofu Li, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e36220-e36220
Open Access | Times Cited: 1
Targeting the Type I IFN Pathway in Glomerular Kidney Disease: Rationale and Therapeutic Opportunities
James A. Tumlin, Brad H. Rovin, Hans‐Joachim Anders, et al.
Kidney International Reports (2024) Vol. 10, Iss. 1, pp. 29-39
Open Access | Times Cited: 1
Fibrosis mechanisms in systemic sclerosis and new potential therapies
Raffaele Barile, Cinzia Rotondo, Valeria Rella, et al.
Postgraduate Medical Journal (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top